• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Ardent Health Partners Inc.

    11/14/24 4:45:09 PM ET
    $ARDT
    Hospital/Nursing Management
    Health Care
    Get the next $ARDT alert in real time by email
    SC 13G 1 tm2428527d1_sc13g.htm SC 13G

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934

     

    (Amendment No.     )*

     

    Ardent Health Partners, Inc.

    (Name of Issuer)

     

    Common Stock, $0.01 par value per share
    (Title of Class of Securities)

     

    03980N107
    (CUSIP Number)

     

    July 17, 2024
     
    (Date of Event which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ¨ Rule 13d-1(b)

     

    ¨ Rule 13d-1(c)

     

    x Rule 13d-1(d)

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

    SCHEDULE 13G

     

    CUSIP No. 03980N107

     

    1

    Names of Reporting Persons

     

    Ventas, Inc.
    2

    Check the appropriate box if a member of a Group (see instructions)

     

    (a) o
    (b) o
    3 Sec Use Only

     

     

    4

    Citizenship or Place of Organization

     

    Delaware

    Number of Shares Beneficially Owned by
    Each Reporting Person With:

     

    5

    Sole Voting Power

     

    9,342,501 (1)
    6 Shared Voting Power
    0
    7

    Sole Dispositive Power

     

    9,342,501 (1)
    8 Shared Dispositive Power
    0
    9

    Aggregate Amount Beneficially Owned by Each Reporting Person

     

    9,342,501 (1)
    10

    Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

     

    ¨
    11

    Percent of class represented by amount in row (9)

     

    6.55% (2)
    12

    Type of Reporting Person (See Instructions)

     

    CO

     

     

    (1) Ventas, Inc.’s beneficial ownership of the Issuer’s common stock consists of 9,342,501 shares of common stock held by ALH Holdings, LLC. Ventas, Inc., as the sole stockholder of VTR AMS, Inc., the sole and managing member of ALH Holdings, LLC, has voting and dispositive power of the shares held by ALH Holdings, LLC.

     

    (2) Calculation based on 142,732,815 shares of the Issuer’s common stock outstanding as of November 7, 2024, as reported in the Issuer’s Form 10-Q for the period ended September 30, 2024.

     

     

     

    Item 1.

     

    (a) Name of Issuer: Ardent Health Partners, Inc.

     

    (b) Address of Issuer’s Principal Executive Offices:

     

    340 Seven Springs Way, Suite 100
    Brentwood, Tennessee 37027

     

    Item 2.

     

    (a) Name of Person Filing: Ventas, Inc.

     

    (b) Address of Principal Business Office or, if None, Residence:

     

    353 N. Clark Street, Suite 3300
    Chicago, Illinois 60654

     

    (c) Citizenship: Ventas, Inc. is a Delaware corporation.

     

    (d) Title of Class of Securities: Common Stock, $0.01 par value per share

     

    (e) CUSIP No.: 03980N107

     

     

     

    Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

     

    (a) ¨ Broker or dealer registered under Section 15 of the Act;

     

    (b) ¨ Bank as defined in Section 3(a)(6) of the Act;

     

    (c) ¨ Insurance company as defined in Section 3(a)(19) of the Act;

     

    (d) ¨ Investment company registered under Section 8 of the Investment Company Act of 1940;

     

    (e) ¨ An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

     

    (f) ¨ An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

     

    (g) ¨ A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

     

    (h) ¨ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

     

    (i) ¨ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940;

     

    (j) ¨ A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J);

     

    (k) ¨ Group, in accordance with § 240.13d-1(b)(1)(ii)(K).

     

    If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____

     

    Item 4. Ownership

     

    (a) Amount Beneficially Owned: 9,342,501 (3)

     

    (b) Percent of Class: 6.55% (4)

     

    (c) Number of shares as to which such person has:

     

    (i) Sole power to vote or to direct the vote:

     

    9,342,501 (3)

     

    (ii) Shared power to vote or to direct the vote:

     

    0

     

    (iii) Sole power to dispose or to direct the disposition of:

     

    9,342,501 (3)

     

    (iv) Shared power to dispose or to direct the disposition of:

     

    0

     

     

     

    Item 5. Ownership of Five Percent or Less of a Class.

     

    N/A.

     

    Item 6. Ownership of more than Five Percent on Behalf of Another Person.

     

    N/A.

     

    Item 7. Identification and classification of the subsidiary which acquired the security being reported on by the parent holding company or control person.

     

    See Exhibit 99.1.

     

    Item 8. Identification and classification of members of the group.

     

    N/A.

     

    Item 9. Notice of Dissolution of Group.

     

    N/A.

     

    Item 10. Certifications.

     

    N/A.

     

     

    (3) Ventas, Inc.’s beneficial ownership of the Issuer’s common stock consists of 9,342,501 shares of common stock held by ALH Holdings, LLC. Ventas, Inc., as the sole stockholder of VTR AMS, Inc., the sole and managing member of ALH Holdings, LLC, has voting and dispositive power of the shares held by ALH Holdings, LLC.

     

    (4) Calculation based on 142,732,815 shares of the Issuer’s common stock outstanding as of November 7, 2024, as reported in the Issuer’s Form 10-Q for the period ended September 30, 2024.

     

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: November 14, 2024

     

    /s/ Carey S. Roberts  
    Name: Carey S. Roberts  
    Title: Executive Vice President, General Counsel, Ethics & Compliance Officer and Corporate Secretary  

     

    The original statement shall be signed by each person on whose behalf the statement is filed or such person’s authorized representative. If the statement is signed on behalf of a person by such person’s authorized representative other than an executive officer or general partner of the filing person, evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement; provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath such person’s signature.

     

    Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001).

     

     

     

    Exhibit 99.1

     

    Identification of the subsidiary which acquired the security being reported on by the parent holding company.

     

    Ventas, Inc.’s beneficial ownership of the Issuer’s common stock consists of 9,342,501 shares of common stock held by ALH Holdings, LLC. Ventas, Inc., as the sole stockholder of VTR AMS, Inc., the sole and managing member of ALH Holdings, LLC, has voting and dispositive power of the shares held by ALH Holdings, LLC.

     

     

    Get the next $ARDT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ARDT

    DatePrice TargetRatingAnalyst
    12/17/2024$20.00Neutral
    Analyst
    11/6/2024$22.00 → $19.00Buy → Neutral
    BofA Securities
    10/11/2024$24.00Overweight
    KeyBanc Capital Markets
    8/12/2024$22.00Buy
    BofA Securities
    8/12/2024$18.00Buy
    Loop Capital
    8/12/2024$24.00Overweight
    Stephens
    8/12/2024$21.00Buy
    Citigroup
    8/12/2024$23.00Outperform
    RBC Capital Mkts
    More analyst ratings

    $ARDT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Ardent Health Appoints Chief Development Officer to Lead Strategic Growth

      Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Chris Schoeplein as chief development officer. In this new role, Schoeplein will lead development efforts across Ardent's existing markets and support the organization's expansion into new regions. He will be responsible for driving growth across inpatient and outpatient care settings through acquisitions, partnerships and joint ventures. Additionally, he will guide due diligence, market intelligence and integration planning to advance Ardent's long-term growth strategy. "We are excited to welcome Chris to Ardent at a pivotal time in our gr

      5/19/25 4:30:00 PM ET
      $ARDT
      Hospital/Nursing Management
      Health Care
    • Ardent Health Reports First Quarter 2025 Results

      Ardent Health Partners, Inc. (NYSE:ARDT) ("Ardent Health" or the "Company"), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced results for the quarter ended March 31, 2025. First Quarter 2025 Operating and Financial Summary All comparisons are versus the same prior year period. See the footnotes to the Operating Statistics table of this press release for definitions of the metrics below and a full list of key operating metrics. Total Revenue $1.50 billion 4.0% growth Y/Y Net Income Attributable to Ardent Health $41 million Adjusted EBITDA(1) $98 million 2.5% growth Y/Y Adjusted EBITDAR(1) $139 million

      5/6/25 4:30:00 PM ET
      $ARDT
      Hospital/Nursing Management
      Health Care
    • Ardent Health to Participate in May Investor Conferences

      Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that members of the Company's management team will participate in the following upcoming investor conferences: Bank of America Securities 2025 Health Care Conference on May 13 and 14, 2025, in Las Vegas, Nevada. Members of the management team will participate in a presentation at 11:40 a.m. ET on Wednesday, May 14, 2025. 2025 RBC Capital Markets Global Healthcare Conference on Tuesday, May 20, 2025, in New York City, New York. Members of the management team will participate in a fireside chat at 8:00 a.m. ET that same day. A live audio webcast of these p

      5/5/25 7:30:00 AM ET
      $ARDT
      Hospital/Nursing Management
      Health Care

    $ARDT
    Financials

    Live finance-specific insights

    See more
    • Ardent Health Reports First Quarter 2025 Results

      Ardent Health Partners, Inc. (NYSE:ARDT) ("Ardent Health" or the "Company"), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced results for the quarter ended March 31, 2025. First Quarter 2025 Operating and Financial Summary All comparisons are versus the same prior year period. See the footnotes to the Operating Statistics table of this press release for definitions of the metrics below and a full list of key operating metrics. Total Revenue $1.50 billion 4.0% growth Y/Y Net Income Attributable to Ardent Health $41 million Adjusted EBITDA(1) $98 million 2.5% growth Y/Y Adjusted EBITDAR(1) $139 million

      5/6/25 4:30:00 PM ET
      $ARDT
      Hospital/Nursing Management
      Health Care
    • Ardent Health Announces First Quarter 2025 Results Conference Call and Webcast Date

      Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it will issue its first quarter 2025 results after the market closes on Tuesday, May 6, 2025. A conference call will be held the following day, Wednesday, May 7, 2025, at 10:00 a.m. ET to review the Company's financial results, discuss recent events and conduct a question-and-answer session. A webcast of the conference call and accompanying presentation materials will be available in the Investor Relations section of Ardent's website at ir.ardenthealth.com. To listen to a live broadcast, go to the site at least 15 minutes prior to the scheduled start time

      4/22/25 4:30:00 PM ET
      $ARDT
      Hospital/Nursing Management
      Health Care
    • Ardent Health Announces Fourth Quarter and Full Year 2024 Results Conference Call and Webcast Date

      Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it will issue its fourth quarter and full year 2024 results after the market closes on Wednesday, February 26, 2025. A conference call will be held the following day, Thursday, February 27, 2025, at 9:00 a.m. ET to review the Company's financial results, discuss recent events and conduct a question-and-answer session. A webcast of the conference call and accompanying presentation materials will be available in the Investor Relations section of Ardent's website at ir.ardenthealth.com. To listen to a live broadcast, go to the site at least 15 minutes prior

      2/5/25 4:30:00 PM ET
      $ARDT
      Hospital/Nursing Management
      Health Care

    $ARDT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Webb Robert Thomas bought $339,600 worth of shares (20,000 units at $16.98), increasing direct ownership by 99% to 40,275 units (SEC Form 4)

      4 - Ardent Health Partners, Inc. (0001756655) (Issuer)

      11/13/24 4:41:55 PM ET
      $ARDT
      Hospital/Nursing Management
      Health Care

    $ARDT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Ardent Health Partners Inc.

      SC 13G - Ardent Health Partners, Inc. (0001756655) (Subject)

      11/14/24 6:07:29 PM ET
      $ARDT
      Hospital/Nursing Management
      Health Care
    • SEC Form SC 13G filed by Ardent Health Partners Inc.

      SC 13G - Ardent Health Partners, Inc. (0001756655) (Subject)

      11/14/24 4:45:09 PM ET
      $ARDT
      Hospital/Nursing Management
      Health Care
    • SEC Form SC 13G filed by Ardent Health Partners Inc.

      SC 13G - Ardent Health Partners, Inc. (0001756655) (Subject)

      11/14/24 4:27:52 PM ET
      $ARDT
      Hospital/Nursing Management
      Health Care

    $ARDT
    Leadership Updates

    Live Leadership Updates

    See more
    • Ardent Health Appoints Chief Development Officer to Lead Strategic Growth

      Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Chris Schoeplein as chief development officer. In this new role, Schoeplein will lead development efforts across Ardent's existing markets and support the organization's expansion into new regions. He will be responsible for driving growth across inpatient and outpatient care settings through acquisitions, partnerships and joint ventures. Additionally, he will guide due diligence, market intelligence and integration planning to advance Ardent's long-term growth strategy. "We are excited to welcome Chris to Ardent at a pivotal time in our gr

      5/19/25 4:30:00 PM ET
      $ARDT
      Hospital/Nursing Management
      Health Care
    • Ardent Health Appoints Robert DeMichiei to Board of Directors

      Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Robert A. DeMichiei to its board of directors. A seasoned leader with over 30 years of experience in financial strategy, healthcare operations, and board governance, Mr. DeMichiei served as executive vice president and chief financial officer at the University of Pittsburgh Medical Center (UPMC) from 2004 to 2020. During his tenure, he played a pivotal role in driving UPMC's financial growth and led numerous strategic initiatives, including mergers and acquisitions, supply chain management, and revenue cycle improvements. Prior to joining U

      4/3/25 5:27:00 PM ET
      $AP
      $ARDT
      $HCAT
      $WAY
      Fluid Controls
      Industrials
      Hospital/Nursing Management
      Health Care
    • Ardent Health Announces Appointment of Chief Operating Officer and Senior Leadership Promotions

      Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Dave Caspers as chief operating officer. In this new role, Caspers will oversee operations across Ardent Health, which includes 30 hospitals and 280 sites of care in six states. He will be responsible for executing on strategic growth initiatives and driving operational excellence at an enterprise level. Caspers will also lead efforts to further optimize and scale the company's consumer-centric operating model across new and existing markets. "We are pleased to welcome Dave to Ardent," said Ardent Health President and CEO Marty Bonick. "His

      3/31/25 4:30:00 PM ET
      $ARDT
      Hospital/Nursing Management
      Health Care

    $ARDT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Analyst resumed coverage on Ardent Health Partners with a new price target

      Analyst resumed coverage of Ardent Health Partners with a rating of Neutral and set a new price target of $20.00

      12/17/24 7:27:59 AM ET
      $ARDT
      Hospital/Nursing Management
      Health Care
    • Ardent Health Partners downgraded by BofA Securities with a new price target

      BofA Securities downgraded Ardent Health Partners from Buy to Neutral and set a new price target of $19.00 from $22.00 previously

      11/6/24 7:16:56 AM ET
      $ARDT
      Hospital/Nursing Management
      Health Care
    • KeyBanc Capital Markets initiated coverage on Ardent Health Partners with a new price target

      KeyBanc Capital Markets initiated coverage of Ardent Health Partners with a rating of Overweight and set a new price target of $24.00

      10/11/24 7:35:47 AM ET
      $ARDT
      Hospital/Nursing Management
      Health Care

    $ARDT
    SEC Filings

    See more
    • SEC Form 10-Q filed by Ardent Health Partners Inc.

      10-Q - Ardent Health Partners, Inc. (0001756655) (Filer)

      5/7/25 4:31:36 PM ET
      $ARDT
      Hospital/Nursing Management
      Health Care
    • Ardent Health Partners Inc. filed SEC Form 8-K: Results of Operations and Financial Condition

      8-K - Ardent Health Partners, Inc. (0001756655) (Filer)

      5/6/25 4:30:35 PM ET
      $ARDT
      Hospital/Nursing Management
      Health Care
    • SEC Form DEFA14A filed by Ardent Health Partners Inc.

      DEFA14A - Ardent Health Partners, Inc. (0001756655) (Filer)

      4/8/25 4:49:14 PM ET
      $ARDT
      Hospital/Nursing Management
      Health Care

    $ARDT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Demichiei Robert was granted 10,073 shares (SEC Form 4)

      4 - Ardent Health Partners, Inc. (0001756655) (Issuer)

      4/4/25 4:47:38 PM ET
      $ARDT
      Hospital/Nursing Management
      Health Care
    • SEC Form 3 filed by new insider Demichiei Robert

      3 - Ardent Health Partners, Inc. (0001756655) (Issuer)

      4/4/25 4:41:50 PM ET
      $ARDT
      Hospital/Nursing Management
      Health Care
    • Chief Operating Officer Caspers Dave covered exercise/tax liability with 2,480 shares and was granted 40,768 shares (SEC Form 4)

      4 - Ardent Health Partners, Inc. (0001756655) (Issuer)

      4/2/25 5:31:49 PM ET
      $ARDT
      Hospital/Nursing Management
      Health Care